Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

With every week we draw closer to the event everyone in the UK is talking about – the general election. …

News
gavel

J&J launches lawsuit to block release of Remicade biosimilar

May 19, 2017
Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis

Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …

News
shutterstock_57369385

Pharma’s Identity Crisis: Four strategies for creating value in life sciences

May 19, 2017
Medical Communications pharmafile

As the demands of healthcare across the world begin to rise, PwC outlines four strategies for creating value in life …

News
facilities_lg06

Dr Reddy’s gets greenlight to market Doxil generic

May 18, 2017
Sales and Marketing Dr Reddy's, FDA

Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …

News
lungs

Off-patent cancer drug holds promise for severe asthma treatment

May 18, 2017
Research and Development asthma, imatinib

Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …

News

FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years

May 18, 2017
Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …

News
pills-384846_960_720

Research suggests opioid crisis stems from prescription approach

May 18, 2017
Medical Communications, Research and Development opioid crisis, opioids

The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …

News
sicorbio

500 staff face the axe as Teva cans Hungary plant

May 18, 2017
Manufacturing and Production Teva

Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, …

News
astrazeneca_building_white

AZ launches lawsuit against former executive for defecting to GSK

May 17, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …

News

Bayer celebrates FDA priority review for investigational blood cancer drug

May 17, 2017
Research and Development, Sales and Marketing Bayer, FDA, blood cancer

Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …

News

T cells found to ‘acquire knowledge’ to take fight to metastatic cancer

May 17, 2017
Research and Development Cancer, T cell, immunotherapy

T cells are widely known as being crucial in the fight against cancer within the body but little was known, …

News

FDA demands new warnings for J&J diabetes drug over amputation risk

May 17, 2017
Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes

Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …

News

Sangamo secures FDA’s Fast Track Designation for haemophilia candidate

May 17, 2017
Research and Development, Sales and Marketing FDA, Pfizer, Sangamo Therapeutics

Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …

News
folder

Common treatment for MS revealed to have potential adverse reactions

May 16, 2017
Manufacturing and Production, Research and Development MS, multiple sclerosis

Beta interferons are a common treatment used to manage multiple sclerosis. The treatment works by reducing and preventing the inflammation …

News

New FDA Commissioner Gottlieb restructures workforce with product-based focus areas

May 16, 2017
Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb

Scott Gottlieb has wasted no time since his appointment to the role of FDA Commissioner last week. As one of …

News

European Commission targets Aspen over 1,500% price hikes

May 16, 2017
Manufacturing and Production, Sales and Marketing European Commission, aspen

The European Commission (EC) has opened its first investigation over drug pricing following alleged hiking by pharma company Aspen, which …

News
ionis

Patient death sparks safety worries in Ionis trial

May 16, 2017
Manufacturing and Production, Research and Development Ionis Pharmaceuticals

Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …

News
cuba

Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s

May 16, 2017
Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …

News

GSK mulls $8 billion healthcare consolidation deal

May 15, 2017
Sales and Marketing GSK, Novartis

When GSK and Novartis first agreed their business swap and healthcare joint venture, it was seen as marking a shift …

News
brexit_flag

Brain drain: The experts the UK may lose due to Brexit

May 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …

Feature
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026